Appendix A: Pediatric Antiretroviral Drug Information
Overview
Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors (NRTIs)
Abacavir
Emtricitabine
Lamivudine
Tenofovir alafenamide
Tenofovir disoproxil fumarate
Zidovudine
Non-Nucleoside Analogue Reverse Transcriptase Inhibitors (NNRTIs)
Doravirine
Efavirenz
Etravirine
Nevirapine
Rilpivirine
Protease Inhibitors (PIs)
Atazanavir
Darunavir
Lopinavir/Ritonavir
Entry and Fusion Inhibitors
Fostemsavir
Ibalizumab
Maraviroc
Integrase Inhibitors (INSTIs)
Bictegravir
Cabotegravir
Dolutegravir
Elvitegravir
Raltegravir
Pharmacokinetic Enhancers
Fixed-Dose Combinations
Antiretrovirals Available in Fixed-Dose Combination Tablets
Antiretroviral Fixed-Dose Combination Tablets: Minimum Body Weights and Considerations for Use in Children and Adolescents
Archived Drugs
Didanosine
Enfuvirtide
Fosamprenavir
Indinavir
Nelfinavir
Saquinavir
Stavudine
Tipranavir
Download Guidelines
- Section OnlyPDF (101.95 KB)
- Full GuidelinePDF (6.11 MB)
- Recommendations OnlyPDF (244.84 KB)
- Tables OnlyPDF (422.62 KB)
- Drug Tables OnlyPDF (754.8 KB)